Skip to content

Metabonomics Study of Chronic Gastritis and Gastric Carcinoma

Metabonomics Study of Chronic Gastritis and Gastric Carcinoma

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04624282
Enrollment
60
Registered
2020-11-10
Start date
2020-11-01
Completion date
2021-05-31
Last updated
2021-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Brief summary

The pathogenetic mechanisms of chronic gastritis and gastric carcinoma are different. Whether metabonomics play a role in the development of chronic gastritis and gastric cancer is still a question. So the investigators want to clarify this question by this subject.

Detailed description

This project was an untargeted metabolomics study using liquid chromatography coupled with mass spectrometry (LC-MS) in patients with chronic gastritis and gastric carcinoma. The experimental procedures mainly include sample collection, metabolite extraction, LC-MS/MS detection, data analysis, etc.The goal of this study is to identify and (relatively) quantify as many metabolites in biological systems as possible, so as to reveal the overall metabolite information to the maximum extent. Metabolomics aims to investigate the changes of metabolites in gastric tissues in patients with chronic gastritis and gastric carcinoma, and to study the biological processes in which these metabolites participate by screening the different metabolites in the different groups, and to reveal the mechanism of life activities in which they involved in.

Interventions

DIAGNOSTIC_TESTdifferent diseases

Patients will be divided into three groups, including chronic superficial gastritis ,chronic atrophic gastritis and gastric carcinoma.

Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Patients with chronic superficial gastritis and chronic atrophic gastritis * Patients with gastric carcinoma

Exclusion criteria

* Patients with history of surgery * Patients with severe heart disease,lung disease or kidney disease.

Design outcomes

Primary

MeasureTime frameDescription
Metabonomic difference in patients with chronic gastritis and gastric carcinomasix months1.The different levels of metabolites in gastric tissues in patients with chronic gastritis and gastric carcinoma. 2. The common change model of metabolites in gastric carcionoma compared with chronic gastritis.

Secondary

MeasureTime frameDescription
Association of different metabolic substances and disease results in chronic gastritis and gastric carcinomasix monthsThe researchers want to reveal the relationship between different metabolic sustances and disease result in patientswith chronic gastritis and gastric carcinoma.

Countries

China

Contacts

Primary ContactYuehua Han, Dr.
13858126927@163.com+86 13858126927

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026